Summary
Mr C complained that the practice failed to discuss the risk of testosterone replacement when it was prescribed to him.
We took independent advice from a GP. We found that at the start of his prescription, there was no evidence in Mr C's medical records to show that the risks and benefits of the treatment had been discussed with him as required by General Medical Council guidance. Therefore, we upheld Mr C's complaint.
Recommendations
What we asked the organisation to do in this case: Apologise to Mr C for the failure to discuss the risks of testosterone therapy with him. The apology should meet the standards set out in the SPSO guidelines on apology available at https://www.spso.org.uk/leaflets-and-guidance.
Related reading
View Decision Report 201800971 as a PDF (24.66 KB) Updated: February 20, 2019